Adiponectin
The fat cell hormone that fights insulin resistance
Plain English
Adiponectin is a hormone produced by fat cells that improves how well your body responds to insulin, reduces inflammation, and supports fat metabolism. Unlike most hormones secreted by fat tissue, adiponectin levels go down as body fat increases, particularly visceral fat. Higher adiponectin is associated with better metabolic health; lower levels are an early marker of developing insulin resistance.
The Mechanism
Adiponectin is secreted primarily by white adipose (fat) tissue, but in an unusual pattern: the more visceral fat you carry, the less adiponectin you produce. The mechanism involves visceral fat cells producing inflammatory signals that suppress adiponectin secretion, creating a feedback loop where fat accumulation directly undermines metabolic protection.
Once circulating, adiponectin binds to receptors (AdipoR1 in muscle, AdipoR2 in liver) and activates the AMPK pathway, which is the same cellular energy sensor that Zone 2 cardio activates. Through AMPK, adiponectin promotes glucose uptake in muscle cells, increases fat oxidation, and reduces hepatic glucose output from the liver, all actions that improve insulin sensitivity. It also suppresses inflammatory signaling in the arterial wall, reducing cardiovascular risk independent of its metabolic effects.
Adiponectin levels vary significantly by sex and body composition: women typically have higher circulating levels than men at the same body fat percentage, and lean individuals have higher levels than those with excess visceral fat. Levels decline substantially in the metabolic syndrome cluster (elevated triglycerides, low HDL, abdominal obesity, elevated glucose), making adiponectin a sensitive integrative marker of metabolic dysfunction before individual markers cross clinical thresholds.
Why It Matters
Higher is better, and the same habits that reduce visceral fat raise adiponectin simultaneously.
Adiponectin is one of the few measurable hormones that is both protective against insulin resistance and lower in people who need that protection most. Low adiponectin predicts type 2 diabetes and cardiovascular disease progression more accurately than fasting glucose in some cohorts. It is a direct readout of how metabolically friendly your fat tissue currently is.
Common Misconception
Most people have never heard of adiponectin, which means they do not realize that fat tissue is not metabolically neutral. Visceral fat actively suppresses the hormone your body needs to stay insulin sensitive. Losing visceral fat is not just about aesthetics; it directly restores adiponectin output.
Signs It Is Disrupted
- Increasing waist circumference with stable or declining muscle mass
- Fasting insulin trending upward year-over-year on labs
- Triglycerides rising and HDL declining on the same lipid panel
- Post-meal energy crashes and persistent afternoon fatigue
- Difficulty losing fat even with consistent dietary effort
How to Improve It
3 Things to Remember
Adiponectin is produced by fat cells, but visceral fat actively suppresses it, creating the paradox where people with the most fat have the least of the hormone that protects against insulin resistance.
Higher adiponectin improves insulin sensitivity, reduces inflammation, and lowers cardiovascular risk, making it a useful integrative marker of how well lifestyle interventions are actually working at the hormonal level.
Zone 2 cardio and visceral fat reduction both raise adiponectin within weeks, giving it a direct feedback relationship with the same lifestyle inputs that drive the rest of the Protocol framework.
Appears In
Related Terms
Protocol
Turn what you've learned into daily practice
Protocol pulls your wearable and nutrition data together into a daily health score, morning brief, and AI coaching. All in one place.
Get started free